There is a proliferation of healthcare data, including both Clinical Trial Data and Real-World Data.  This creates an unprecedented opportunity for CMOs, Medical Affairs, and RWE groups to drive insights to accelerate not only decision-making in R&D, but also medical evidence generation and peri/post-launch medical engagement – from natural history studies, unmet medical needs analytics, patient identification, lifecycle extension, market access, and HEOR.  This webinar will address key considerations and best practices when combining clinical trial data with real world data to power big data analytics.

Featured Speakers

Akiko Shimamura

Senior Director of Product, Medical Analytics

Medidata AI, a Medidata Company

Akiko has over 10 years of experience in the life sciences industry, previously at McKinsey & Company advising pharmaceutical clients in strategy, digital and advanced analytics.  She holds an MBA from London Business School and a BA in Law from the University of Tokyo.

Aaron Galaznik, MD

VP of Research, Real World Evidence

Medidata AI, a Medidata Company

Dr. Galaznik has over 10 years of experience in the life sciences industry, with previous roles in RWD, HEOR, Market Access and Commercial Analytics at Takeda Oncology and Pfizer. He received his AB in Biology from Harvard University, his MD from Weill Medical College of Cornell University, and his MBA in Healthcare Management from the Wharton School.